<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Med Genet</journal-id><journal-title>BMC Medical Genetics</journal-title><issn pub-type="epub">1471-2350</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1471-2350-7-57</article-id><article-id pub-id-type="pmid">16820065</article-id><article-id pub-id-type="doi">10.1186/1471-2350-7-57</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>&#x003b2;3-adrenergic receptor gene, body mass index, bone mineral density and fracture risk in elderly men and women: the Dubbo Osteoporosis Epidemiology Study (DOES)</article-title></title-group><contrib-group><contrib id="A1" equal-contrib="yes" contrib-type="author"><name><surname>Wang</surname><given-names>Claire Y</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>iamclairewang@hotmail.com</email></contrib><contrib id="A2" equal-contrib="yes" contrib-type="author"><name><surname>Nguyen</surname><given-names>Nguyen D</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>n.nguyen@garvan.org.au</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Morrison</surname><given-names>Nigel A</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>n.morrison@griffith.edu.au</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Eisman</surname><given-names>John A</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>j.eisman@garvan.org.au</email></contrib><contrib id="A5" contrib-type="author"><name><surname>Center</surname><given-names>Jacqueline R</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>j.center@garvan.org.au</email></contrib><contrib id="A6" corresp="yes" contrib-type="author"><name><surname>Nguyen</surname><given-names>Tuan V</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>t.nguyen@garvan.org.au</email></contrib></contrib-group><aff id="I1"><label>1</label>Bone and Mineral Research Program, Garvan Institute of Medical Research, St Vincent's Hospital, University of New South Wales, Sydney, NSW, Australia</aff><aff id="I2"><label>2</label>Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia</aff><aff id="I3"><label>3</label>School of Medical Science, Griffith University, QLD, Australia</aff><pub-date pub-type="collection"><year>2006</year></pub-date><pub-date pub-type="epub"><day>5</day><month>7</month><year>2006</year></pub-date><volume>7</volume><fpage>57</fpage><lpage>57</lpage><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2350/7/57"/><history><date date-type="received"><day>31</day><month>3</month><year>2006</year></date><date date-type="accepted"><day>5</day><month>7</month><year>2006</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2006 Wang et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2006</copyright-year><copyright-holder>Wang et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author> Wang Y Claire iamclairewang@hotmail.com </dc:author><dc:title> &#x003b2;3-adrenergic receptor gene, body mass index, bone mineral density and fracture risk in elderly men and women: the Dubbo Osteoporosis Epidemiology Study (DOES) </dc:title><dc:date>2006</dc:date><dcterms:bibliographicCitation>BMC Medical Genetics 7(1): 57-. (2006)</dcterms:bibliographicCitation><dc:identifier type="sici">1471-2350(2006)7:1&#x0003c;57&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1471-2350</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><sec><title>Background</title><p>Recent studies have suggested that the <italic>Arg </italic>allele of &#x003b2;3-adrenergic receptor (ADRB3) gene is associated with body mass index (BMI), which is an important predictor of bone mineral density (BMD) and fracture risk. However, whether the ADRB3 gene polymorphism is associated with fracture risk has not been investigated. The aim of study was to examine the inter-relationships between ADRB3 gene polymorphisms, BMI, BMD and fracture risk in elderly Caucasians.</p></sec><sec sec-type="methods"><title>Methods</title><p>Genotypes of the ADRB3 gene were determined in 265 men and 446 women aged 60+ in 1989 at entry into the study, whose BMD were measured by DXA (GE Lunar, WI USA) at baseline. During the follow-up period (between 1989 and 2004), fractures were ascertained by reviewing radiography reports and personal interviews.</p></sec><sec><title>Results</title><p>The allelic frequencies of the <italic>Trp </italic>and the <italic>Arg </italic>alleles were 0.925 and 0.075 respectively, and the relative frequencies of genotypes <italic>Trp/Trp</italic>, <italic>Trp/Arg </italic>and <italic>Arg/Arg </italic>0.857, 0.138 and 0.006 respectively. There was no significant association between BMI and ADRB3 genotypes (p = 0.10 in women and p = 0.68 in men). There was also no significant association between ADRB3 genotypes and lumbar spine or femoral neck BMD in either men and women. Furthermore, there were no significant association between ADRB3 genotypes and fracture risk in both women and men, either before or after adjusting for and, BMD and BMI.</p></sec><sec><title>Conclusion</title><p>The present data suggested that in Caucasian population the contribution of ADRB3 genotypes to the prediction of BMI, BMD and fracture risk is limited.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>Osteoporosis and obesity are two common disorders that affect a large number of elderly in the general population [<xref ref-type="bibr" rid="B1">1</xref>-<xref ref-type="bibr" rid="B3">3</xref>]. Approximately 30% of women and 12% of men are affected by osteoporosis or low bone mass at some point during life [<xref ref-type="bibr" rid="B4">4</xref>]. Moreover, about 31% of elderly men and 35% of elderly women are classified as having obesity in the US [<xref ref-type="bibr" rid="B5">5</xref>]. Several lines of epidemiologic evidence suggest that the two disorders may be inversely associated, with obese individuals having higher bone mineral density (BMD) and reduced risk of fracture than non-obese individuals [<xref ref-type="bibr" rid="B6">6</xref>-<xref ref-type="bibr" rid="B11">11</xref>]. Indeed, it has been well-known that between 23% and 47% variance of BMD in the general population can be "explained" by the variation in body mass index (BMI) [<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B13">13</xref>], making BMI one of the most robust and consistent predictors of BMD [<xref ref-type="bibr" rid="B14">14</xref>]. Both body weight (or BMI) and BMD are partly genetically determined. Twin studies have suggested that genetic factors may account for up to 80% of the BMD variance [<xref ref-type="bibr" rid="B15">15</xref>-<xref ref-type="bibr" rid="B17">17</xref>]. Likewise, between 43 to 70% of BMI variance is attributable to genetic factors [<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B19">19</xref>]. Under the hypothesis of shared genetic effects, a gene that is associated with BMI may also protect against osteoporosis.</p><p>The variation in BMD is mainly attributable to genetic factors [<xref ref-type="bibr" rid="B16">16</xref>,<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B20">20</xref>] and the liability to osteoporotic fracture is also partly determined by genetic factor [<xref ref-type="bibr" rid="B21">21</xref>-<xref ref-type="bibr" rid="B23">23</xref>]. Experimental evidence suggested that &#x003b2;3-adrenergic stimulation can induce expression of osteoclast differentiation factor in osteoblast cells, leading to a stimulation of osteoclastogenesis [<xref ref-type="bibr" rid="B24">24</xref>]. Moreover, the activation of &#x003b2;3-adrenergic receptors on two osteoblast-like cells can cause bone resorption in intact mouse calvariae [<xref ref-type="bibr" rid="B25">25</xref>]. In epidemiological studies, the &#x003b2;3-adrenergic receptor (ADRB3) polymorphisms have been found to be associated with BMI [<xref ref-type="bibr" rid="B26">26</xref>] and BMD [<xref ref-type="bibr" rid="B27">27</xref>]. However, such associations, while largely found in the Japanese population, have not been well studied in Caucasian populations. Moreover, the association between ADRB3 polymorphisms and fracture risk, the ultimate outcome of osteoporosis has not been reported. The present study was aimed at examining the inter-relationships between ADRB3 gene polymorphisms, body mass index, bone mineral density and fracture risk in a well-defined sample of elderly Caucasians.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Study design and setting</title><p>The present study was part of the Dubbo Osteoporosis Epidemiology Study (DOES), of which the details of study design and protocols have been described previously [<xref ref-type="bibr" rid="B28">28</xref>-<xref ref-type="bibr" rid="B30">30</xref>]. Briefly, DOES is a community-based, epidemiological study, where participants were recruited from the Dubbo city, a semi-urban city 400 km northwest of Sydney, Australia, with a population of approximately 32 000 people, 98.6% Caucasian, of whom 1 581 men and 2 095 women were aged 60 years or above in 1989. Dubbo's relative isolation in terms of medical care allows virtually complete ascertainment of all fractures. From 1993, blood samples were collected from individuals who volunteer to donate at initial visits or follow-up visits. Our present study reports data on a random sample of 446 women and 265 men aged 60 years or above in 1989, who had consented to donate blood for DNA analysis.</p></sec><sec><title>Measurements</title><p>After obtaining written informed consent, participants were interviewed by a trained research nurse at initial and subsequent visits at approximately 2-year intervals. A structured questionnaire was used to collect data including age, anthropometric variables, life style and clinical data [<xref ref-type="bibr" rid="B31">31</xref>]. Bone mineral density (g/cm<sup>2</sup>) was measured at the lumbar spine and femoral neck by dual-energy X-ray absorptiometry (DXA) using a Lunar DPX-L densitometer (GE Lunar, WI. USA). The measurement was performed at the same visit or within one month of the blood sample collection in 99% of cases. In the cases in which the blood was taken at a time other than the scheduled visit, the BMD used was that closest to the time of blood collection.</p></sec><sec><title>Ascertainment of fracture</title><p>The incidence of fracture was ascertained during the study period (1989&#x02013;2004) by radiologist's report and confirmed by personal interview. Only low trauma fractures were included (i.e. a fall from the standing height or less). Fractures due to motor vehicle accidents or pathological conditions were excluded. Fractures were categorised into 4 groups: hip, symptomatic vertebral, Colles' and other fractures.</p></sec><sec><title>Genotyping</title><p>Genomic DNA was extracted from peripheral blood leukocytes. The ADRB3 polymorphism was determined by polymerase chain reaction (PCR) performed with 20 ng of genomic DNA with upstream primer 5' CCA GTG GGC TGC CGA GGG 3' and downstream primer 5' GCC AGT GGC GCC CAA CGG 3' [<xref ref-type="bibr" rid="B32">32</xref>]. The amplification products were digested with the restriction enzyme <italic>Bst</italic>OI (Promega, Madison, WI, USA) and genotyped as <italic>Trp </italic>homozygotes (<italic>Trp</italic>/<italic>Trp</italic>), heterozygotes (<italic>Trp</italic>/<italic>Arg</italic>), or <italic>Arg </italic>homozygotes (<italic>Arg</italic>/<italic>Arg</italic>). This <italic>Trp</italic>64<italic>Arg </italic>polymorphism has been commonly used in genetic epidemiological studies.</p></sec><sec><title>Statistical analysis</title><p>Alleles were counted and the genotype frequencies of the polymorphism was checked for Hardy-Weinberg equilibrium (HWE) by the likelihood Chi-square statistic [<xref ref-type="bibr" rid="B33">33</xref>]. The baseline characteristics of the subjects in the fracture group and the non-fracture group were compared using descriptive statistical tests with appropriate techniques (e.g. Student's t-test for normally distributed variables, such as BMI and BMD) and Chi-square (for categorical data), depends on the distribution of the variables. The association between each polymorphism and BMD or BMI was analyzed by the analysis of covariance (ANCOVA) model taking into account the effects of potential covariates such as age, weight and life-style factors.</p><p>In order to quantify the risk of sustaining a fracture in relation to ADRB3 genotypes, subjects were grouped into those with <italic>Arg </italic>allele and those without <italic>Arg </italic>allele. The association was analyzed by the logistic regression model taking into account the effects of potential confounders.</p><p>In order to determine the association between BMI and ADRB3 polymorphisms, a Bayesian approach was used [<xref ref-type="bibr" rid="B34">34</xref>,<xref ref-type="bibr" rid="B35">35</xref>]. In the Bayesian analysis, the currently observed data are combined with known data to derive a "posterior distribution" with credible interval. In the present study, a prior mean difference (M<sub>0</sub>) in BMI between subjects with and without <italic>Arg </italic>allele was obtained from a meta-analysis [<xref ref-type="bibr" rid="B26">26</xref>] with a 95% confidence interval (95%CI) being (L<sub>0</sub>, U<sub>0</sub>), from which the standard deviation (SD<sub>0</sub>) for the prior distribution was calculated as follow: SD<sub>0 </sub>= (U<sub>0</sub>- L<sub>0</sub>)/3.92, assuming the difference follows the normal distribution. In order to construct a posterior distribution with mean (M<sub>p</sub>) and standard deviation (SD<sub>p</sub>), the prior distribution was combined with the present study's data, which has a mean of M<sub>d </sub>and standard deviation of SD<sub>d</sub>. The posterior mean and SD are: M<sub>p </sub>=(SD<sub>p</sub>)<sup>2 </sup>[(M<sub>0</sub>/SD<sub>0</sub><sup>2</sup>)+(M<sub>d</sub>/SD<sub>d </sub><sup>2</sup>)] and SD<sub><italic>p </italic></sub>= 1/<inline-formula><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M1" name="1471-2350-7-57-i1" overflow="scroll"><mml:semantics definitionURL="" encoding=""><mml:mrow><mml:msqrt><mml:mrow><mml:msup><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo>/</mml:mo><mml:mi>S</mml:mi><mml:msub><mml:mi>D</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo>+</mml:mo><mml:msup><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo>/</mml:mo><mml:mi>S</mml:mi><mml:msub><mml:mi>D</mml:mi><mml:mi>d</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:msqrt></mml:mrow><mml:annotation encoding="MathType-MTEF"> MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaadaGcaaqaaiabcIcaOiabigdaXiabc+caViabdofatjabdseaenaaBaaaleaacqaIWaamaeqaaOGaeiykaKYaaWbaaSqabeaacqaIYaGmaaGccqGHRaWkcqGGOaakcqaIXaqmcqGGVaWlcqWGtbWucqWGebardaWgaaWcbaGaemizaqgabeaakiabcMcaPmaaCaaaleqabaGaeGOmaidaaaqabaaaaa@3E21@</mml:annotation></mml:semantics></mml:math></inline-formula>. Thus, the posterior mean is a weighted average of two estimates (prior mean and the present study's mean) with the weight being the inverse variances. The analysis was conducted via the SAS system [<xref ref-type="bibr" rid="B36">36</xref>].</p></sec></sec><sec><title>Results</title><sec><title>Characteristics of study subjects</title><p>In total, 446 women and 265 men who had been followed-up for the median of 13.2 years (interquartile range, IQR: 10.4&#x02013;14.1) and 12.9 years (IQR: 9.0&#x02013;14.0) for women and men, respectively.</p><p>The frequencies of the <italic>Trp</italic>/<italic>Trp</italic>, <italic>Trp</italic>/<italic>Arg </italic>and <italic>Arg</italic>/<italic>Arg </italic>genotypes were 385 (86.3%), 58 (13.0%) and 3 (0.7%) respectively for women, and 224 (84.5), 40 (15.1%) and 1 (0.4%) respectively for men. In both sexes, the allelic frequencies of <italic>Trp </italic>allele and <italic>Arg </italic>allele were 0.925 and 0.075 respectively. Because the frequency of <italic>Arg </italic>allele was low in the population, individuals with <italic>Trp</italic>/<italic>Arg </italic>and <italic>Arg</italic>/<italic>Arg </italic>genotypes were considered as one group. The overall genotype distribution in the study subjects was in Hardy-Weinberg equilibrium (&#x003c7;<sup>2 </sup>= 0.007, p = 0.98).</p><p>Clinical characteristics of subjects were stratified by the presence or absence of <italic>Arg </italic>allele (Table <xref ref-type="table" rid="T1">1</xref>). The presence of <italic>Arg </italic>allele in women is associated with a 0.25 SD increase in body weight, but this difference was not statistically significant (p = 0.08). In both women and men, there were no statistically significant differences between <italic>Arg </italic>allele carriers and non-carriers in terms of anthropometric characteristics and lifestyle factors.</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Baseline characteristics of subjects stratified by ADRB3 genotype</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td align="center"><italic>Trp</italic>/<italic>Trp</italic></td><td align="center"><italic>Trp</italic>/<italic>Arg </italic>+ <italic>Arg</italic>/<italic>Arg</italic></td><td align="center">Standardized difference</td><td align="left">P value</td></tr></thead><tbody><tr><td align="left"><bold>Women (N)</bold></td><td align="center">385</td><td align="center">61</td><td></td><td></td></tr><tr><td align="left">&#x02003;Age (y)</td><td align="center">71 &#x000b1; 8</td><td align="center">71 &#x000b1; 6</td><td align="center">0.00</td><td align="left">0.47</td></tr><tr><td align="left">&#x02003;Weight (kg)</td><td align="center">64 &#x000b1; 12</td><td align="center">67 &#x000b1; 13</td><td align="center">0.25</td><td align="left">0.08</td></tr><tr><td align="left">&#x02003;Height (cm)</td><td align="center">160 &#x000b1; 6</td><td align="center">160 &#x000b1; 6</td><td align="center">0.00</td><td align="left">0.90</td></tr><tr><td align="left">&#x02003;BMI (kg/m<sup>2</sup>)</td><td align="center">25 &#x000b1; 5</td><td align="center">26 &#x000b1; 5</td><td align="center">0.20</td><td align="left">0.10</td></tr><tr><td align="left">&#x02003;Ca intake (mg/day)</td><td align="center">644 &#x000b1; 372</td><td align="center">650 &#x000b1; 355</td><td align="center">0.02</td><td align="left">0.90</td></tr><tr><td align="left">&#x02003;Physical activity (METs)</td><td align="center">80 &#x000b1; 30</td><td align="center">82 &#x000b1; 23</td><td align="center">0.07</td><td align="left">0.54</td></tr><tr><td align="left">&#x02003;Femoral neck BMD (g/cm<sup>2</sup>)</td><td align="center">0.76 &#x000b1; 0.13</td><td align="center">0.79 &#x000b1; 0.13</td><td align="center">0.23</td><td align="left">0.24</td></tr><tr><td align="left">&#x02003;Lumbar spine BMD (g/cm<sup>2</sup>)</td><td align="center">1.00 &#x000b1; 0.18</td><td align="center">1.04 &#x000b1; 0.21</td><td align="center">0.22</td><td align="left">0.11</td></tr><tr><td align="left">&#x02003;Age of menopause (y)</td><td align="center">47 &#x000b1; 7</td><td align="center">46 &#x000b1; 7</td><td align="center">-0.14</td><td align="left">0.52</td></tr><tr><td align="left">&#x02003;Current/ex smoker <sup>a,b</sup></td><td align="center">106 (27.5)</td><td align="center">22 (36.1)</td><td></td><td align="left">1.87</td></tr><tr><td colspan="5"><hr></hr></td></tr><tr><td align="left"><bold>Men (N)</bold></td><td align="center">224</td><td align="center">41</td><td></td><td></td></tr><tr><td align="left">&#x02003;Age (y)</td><td align="center">70 &#x000b1; 6</td><td align="center">68 &#x000b1; 5</td><td align="center">-0.34</td><td align="left">0.12</td></tr><tr><td align="left">&#x02003;Weight (kg)</td><td align="center">78 &#x000b1; 12</td><td align="center">77 &#x000b1; 13</td><td align="center">-0.08</td><td align="left">0.46</td></tr><tr><td align="left">&#x02003;Height (cm)</td><td align="center">174 &#x000b1; 6</td><td align="center">173 &#x000b1; 8</td><td align="center">-0.16</td><td align="left">0.77</td></tr><tr><td align="left">&#x02003;BMI (kg/m<sup>2</sup>)</td><td align="center">26 &#x000b1; 3</td><td align="center">26 &#x000b1; 4</td><td align="center">0.00</td><td align="left">0.68</td></tr><tr><td align="left">&#x02003;Ca intake (mg/day)</td><td align="center">657 &#x000b1; 367</td><td align="center">732 &#x000b1; 317</td><td align="center">0.21</td><td align="left">0.23</td></tr><tr><td align="left">&#x02003;Physical activity (METs)</td><td align="center">76 &#x000b1; 49</td><td align="center">72 &#x000b1; 48</td><td align="center">-0.08</td><td align="left">0.69</td></tr><tr><td align="left">&#x02003;Femoral neck BMD (g/cm<sup>2</sup>)</td><td align="center">0.92 &#x000b1; 0.15</td><td align="center">0.93 &#x000b1; 0.15</td><td align="center">0.07</td><td align="left">0.63</td></tr><tr><td align="left">&#x02003;Lumbar spine BMD (g/cm<sup>2</sup>)</td><td align="center">1.26 &#x000b1; 0.21</td><td align="center">1.24 &#x000b1; 0.24</td><td align="center">-0.09</td><td align="left">0.59</td></tr><tr><td align="left">&#x02003;Current/ex smoker <sup>a,b</sup></td><td align="center">122 (54.5)</td><td align="center">25 (61.0)</td><td></td><td align="left">0.59</td></tr></tbody></table><table-wrap-foot><p>Values are mean &#x000b1; SD, otherwise specified; P values were calculated using unpaired t-test, otherwise specified. BMI, body mass index; Ca, calcium; METs, metabolic equivalents.</p><p><sup>a </sup>N(%); <sup>b</sup>Chi-square test.</p></table-wrap-foot></table-wrap></sec><sec><title>ADRB3 genotypes and BMI</title><p>In the present study, there was no significant association between ADRB3 genotypes and BMI. The overall mean difference in BMI for <italic>Arg </italic>carriers versus non-carriers was 0.54 kg/m<sup>2 </sup>(95% CI: -0.35, 1.44; P = 0.23), or 0.13 SD. In a previous meta-analysis [<xref ref-type="bibr" rid="B26">26</xref>], <italic>Arg </italic>carriers had higher BMI than non-<italic>Arg </italic>carriers by 0.30 (95% CI, 0.13&#x02013;0.47) kg/m<sup>2 </sup>as indicated in the prior distribution (Figure <xref ref-type="fig" rid="F1">1</xref>). After updating the previous data with the present study's data, the posterior distribution showed that BMI in the <italic>Arg </italic>allele carriers are, on average, 0.31 kg/m<sup>2 </sup>(95% CI, 0.14&#x02013;0.48) higher than non-<italic>Arg </italic>carriers.</p><fig position="float" id="F1"><label>Figure 1</label><caption><p>Posterior distribution of mean difference in BMI (kg/m<sup>2</sup>) between <italic>Arg </italic>carriers and non-<italic>Arg </italic>carriers.</p></caption><graphic xlink:href="1471-2350-7-57-1"/></fig></sec><sec><title>ADRB3 genotypes and BMD</title><p>In multiple regression analysis of BMD measurements at both lumbar spine and femoral neck (Table <xref ref-type="table" rid="T2">2</xref>), there were no significant associations between ADRB3 and BMD at both LS and FN sites. However, in both women and men, age and smoking history were negatively associated with femoral neck BMD, and BMI was positively associated with lumbar spine and femoral neck BMD. Although increased physical activity was not associated with BMD measured at femoral neck, it was positively associated with lumbar spine BMD. Collectively these factors (age, BMI, smoking history, calcium intake, physical activity and ADRB3 genotypes) explained about 30% and 12% of variances in femoral neck BMD in women and men respectively.</p><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>ADRB3 genotype and BMD: Standardized regression coefficient from the multiple regression analyses</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td align="center" colspan="2">LSBMD</td><td align="center" colspan="2">FNBMD</td></tr><tr><td></td><td colspan="4"><hr></hr></td></tr><tr><td></td><td align="center">Coefficient</td><td align="center">P value</td><td align="center">Coefficient</td><td align="center">P value</td></tr></thead><tbody><tr><td align="left"><bold>Women</bold></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">&#x02003;Age</td><td align="center">-0.040</td><td align="center">0.380</td><td align="center">-0.344</td><td align="center">&#x0003c;0.01</td></tr><tr><td align="left">&#x02003;BMI</td><td align="center">0.366</td><td align="center">&#x0003c;0.01</td><td align="center">0.382</td><td align="center">&#x0003c;0.01</td></tr><tr><td align="left">&#x02003;Smoking</td><td align="center">-0.041</td><td align="center">0.37</td><td align="center">-0.087</td><td align="center">0.03</td></tr><tr><td align="left">&#x02003;Calcium intake</td><td align="center">-0.018</td><td align="center">0.69</td><td align="center">0.050</td><td align="center">0.23</td></tr><tr><td align="left">&#x02003;Physical activity</td><td align="center">0.140</td><td align="center">&#x0003c;0.01</td><td align="center">0.035</td><td align="center">0.40</td></tr><tr><td align="left">&#x02003;ADRB3<sup>a</sup></td><td align="center">0.044</td><td align="center">0.33</td><td align="center">0.046</td><td align="center">0.26</td></tr><tr><td align="left">&#x02003;R<sup>2</sup></td><td align="center">0.162</td><td></td><td align="center">0.302</td><td></td></tr><tr><td colspan="5"><hr></hr></td></tr><tr><td align="left"><bold>Men</bold></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">&#x02003;Age</td><td align="center">-0.018</td><td align="center">0.78</td><td align="center">-0.187</td><td align="center">&#x0003c;0.01</td></tr><tr><td align="left">&#x02003;BMI</td><td align="center">0.231</td><td align="center">&#x0003c;0.01</td><td align="center">0.240</td><td align="center">&#x0003c;0.01</td></tr><tr><td align="left">&#x02003;Smoking</td><td align="center">-0.104</td><td align="center">0.09</td><td align="center">-0.149</td><td align="center">&#x0003c;0.01</td></tr><tr><td align="left">&#x02003;Calcium intake</td><td align="center">0.091</td><td align="center">0.14</td><td align="center">0.048</td><td align="center">0.01</td></tr><tr><td align="left">&#x02003;Physical activity</td><td align="center">0.124</td><td align="center">0.05</td><td align="center">0.036</td><td align="center">0.43</td></tr><tr><td align="left">&#x02003;ADRB3<sup>a</sup></td><td align="center">0.001</td><td align="center">0.99</td><td align="center">0.003</td><td align="center">0.60</td></tr><tr><td align="left">&#x02003;R<sup>2</sup></td><td align="center">0.074</td><td></td><td align="center">0.120</td><td></td></tr></tbody></table><table-wrap-foot><p>LSBMD, lumbar spine bone mineral density; FNBMD, femoral neck bone mineral density.</p><p>R<sup>2</sup>: coefficient of determination; proportion of variance of BMD (LSBMD or FNBMD) accounted for by all the factors in the model. <sup>a</sup>Non-<italic>Arg </italic>allele carrier and <italic>Arg </italic>allele carrier.</p></table-wrap-foot></table-wrap></sec><sec><title>ADRB3 genotypes and fracture risk</title><p>During the follow up period, 173 women and 49 men had sustained at least one osteoporotic fracture. In women, the most common fracture site was distal radius (Colles' fracture) with an incidence rate of 24% of all the cases, followed by vertebral (23%) and hip (14%). In men, the most common fracture site was vertebrae (41%), followed by hip (16%) and ribs (14%). For both women and men, fracture individuals were older, weighed less, and had lower BMD at both femoral neck and lumbar spine compared to their non-fracture counterparts (Table <xref ref-type="table" rid="T3">3</xref>). However, there was no significant difference between the fracture group and non-fracture group in terms of calcium intake, physical activity and smoking history.</p><table-wrap position="float" id="T3"><label>Table 3</label><caption><p>Baseline characteristics of subjects with and without fracture</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td align="center">Any fracture</td><td align="center">Non-fracture</td><td align="center">Mean difference (95% CI)</td><td align="center">SD<sup>a</sup></td><td align="center">P value</td></tr></thead><tbody><tr><td align="left"><bold>Women</bold></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">Number of subjects</td><td align="center">173</td><td align="center">273</td><td></td><td></td><td></td></tr><tr><td align="left">Age (y)</td><td align="center">72 &#x000b1; 8</td><td align="center">70 &#x000b1; 7</td><td align="center">1.86 (0.46, 3.226)</td><td align="center">0.27</td><td align="center">&#x0003c;0.01</td></tr><tr><td align="left">Weight (kg)</td><td align="center">63 &#x000b1; 12</td><td align="center">66 &#x000b1; 12</td><td align="center">-2.76 (-5.14, -0.38)</td><td align="center">-0.25</td><td align="center">0.03</td></tr><tr><td align="left">Height (cm)</td><td align="center">159 &#x000b1; 7</td><td align="center">160 &#x000b1; 6</td><td align="center">-0.89 (-2.06, 0.27)</td><td align="center">-0.16</td><td align="center">0.13</td></tr><tr><td align="left">BMI (kg/m<sup>2</sup>)</td><td align="center">25 &#x000b1; 4</td><td align="center">26 &#x000b1; 5</td><td align="center">-0.88 (-1.76, 0)</td><td align="center">-0.22</td><td align="center">0.05</td></tr><tr><td align="left">Ca intake (mg/day)</td><td align="center">640 &#x000b1; 379</td><td align="center">648 &#x000b1; 364</td><td align="center">-7.70 (-78.93, 63.52)</td><td align="center">-0.02</td><td align="center">0.83</td></tr><tr><td align="left">Physical activity (METs)</td><td align="center">83 &#x000b1; 32</td><td align="center">79 &#x000b1; 27</td><td align="center">3.67 (-1.99, 9.32)</td><td align="center">0.14</td><td align="center">0.20</td></tr><tr><td align="left">Femoral neck BMD (g/cm<sup>2</sup>)</td><td align="center">0.72 &#x000b1; 0.12</td><td align="center">0.80 &#x000b1; 0.13</td><td align="center">-0.07 (-0.10, -0.05)</td><td align="center">-0.63</td><td align="center">&#x0003c;0.01</td></tr><tr><td align="left">Lumbar spine BMD (g/cm<sup>2</sup>)</td><td align="center">0.95 &#x000b1; 0.17</td><td align="center">1.04 &#x000b1; 0.19</td><td align="center">-0.09 (-0.12, -0.05)</td><td align="center">-0.49</td><td align="center">&#x0003c;0.01</td></tr><tr><td align="left">Age of menopause (y)</td><td align="center">46 &#x000b1; 8</td><td align="center">47 &#x000b1; 7</td><td align="center">-1.46 (-2.86, -0.06)</td><td align="center">-0.14</td><td align="center">0.04</td></tr><tr><td align="left">Current/ex smoker <sup>b,c</sup></td><td align="center">46 (26.6)</td><td align="center">82 (30.0)</td><td></td><td></td><td align="center">0.43</td></tr><tr><td colspan="6"><hr></hr></td></tr><tr><td align="left"><bold>Men</bold></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">Number of subjects</td><td align="center">49</td><td align="center">216</td><td></td><td></td><td></td></tr><tr><td align="left">Age (y)</td><td align="center">73 &#x000b1; 6</td><td align="center">69 &#x000b1; 6</td><td align="center">3.54 (1.73, 5.36)</td><td align="center">0.67</td><td align="center">&#x0003c;0.01</td></tr><tr><td align="left">Weight (kg)</td><td align="center">75 &#x000b1; 11</td><td align="center">79 &#x000b1; 12</td><td align="center">-4.05 (-7.81, -0.29)</td><td align="center">-0.34</td><td align="center">0.03</td></tr><tr><td align="left">Height (cm)</td><td align="center">171 &#x000b1; 7</td><td align="center">174 &#x000b1; 6</td><td align="center">-2.75 (-4.82, -0.69)</td><td align="center">-0.48</td><td align="center">0.01</td></tr><tr><td align="left">BMI (kg/m<sup>2</sup>)</td><td align="center">25 &#x000b1; 3</td><td align="center">26 &#x000b1; 4</td><td align="center">-0.54 (-1.64, 0.55)</td><td align="center">-0.26</td><td align="center">0.33</td></tr><tr><td align="left">Ca intake (mg/day)</td><td align="center">693 &#x000b1; 475</td><td align="center">663 &#x000b1; 330</td><td align="center">29.77 (-83.66, 143.19)</td><td align="center">0.08</td><td align="center">0.61</td></tr><tr><td align="left">Physical activity (METs)</td><td align="center">84 &#x000b1; 53</td><td align="center">73 &#x000b1; 47</td><td align="center">11.19 (-4.59, 26.98)</td><td align="center">0.23</td><td align="center">0.16</td></tr><tr><td align="left">Femoral neck BMD (g/cm<sup>2</sup>)</td><td align="center">0.85 &#x000b1; 0.13</td><td align="center">0.94 &#x000b1; 0.15</td><td align="center">-0.09 (-0.14, -0.05)</td><td align="center">-0.61</td><td align="center">&#x0003c;0.01</td></tr><tr><td align="left">Lumbar spine BMD (g/cm<sup>2</sup>)</td><td align="center">1.14 &#x000b1; 0.20</td><td align="center">1.28 &#x000b1; 0.21</td><td align="center">-0.14 (-0.21, -0.07)</td><td align="center">-0.67</td><td align="center">&#x0003c;0.01</td></tr><tr><td align="left">Current/ex smoker <sup>b, c</sup></td><td align="center">33 (67.3)</td><td align="center">114 (52.8)</td><td></td><td></td><td align="center">0.06</td></tr></tbody></table><table-wrap-foot><p>Values are mean &#x000b1; SD, otherwise specified; P values are calculated using unpaired t-test, otherwise specified. BMI, body mass index; Ca, calcium; METs, metabolic equivalents;</p><p><sup>a </sup>Standardized difference; <sup>b</sup>Chi-square test; <sup>c</sup>N(%).</p></table-wrap-foot></table-wrap><p>The distribution of ADRB3 genotypes in fracture and non-fracture subjects is shown in Table <xref ref-type="table" rid="T4">4</xref>. Women with the <italic>Arg/Arg </italic>and <italic>Trp/Arg </italic>genotypes had lower incident rate of any fracture than those with the <italic>Trp/Trp </italic>genotype, but the difference was not statistically significant (32.8% vs. 39.7%, p = 0.30). This non-significant association was observed for all specific fracture sites. However, in men, individuals with the <italic>Arg/Arg </italic>and <italic>Trp/Arg </italic>genotypes had higher incident rate of any fracture than those with the <italic>Trp/Trp </italic>genotype (22.0% vs. 17.9%); the difference was also not statistically significant (p = 0.53). After adjusting for age, BMI and/or BMD, the associations between the ADRB3 polymorphism and fracture risk in women and men were not statistically significant (Table <xref ref-type="table" rid="T5">5</xref>). There were no interaction effects between ADRB3 genotypes and age on fracture risk (data not shown).</p><table-wrap position="float" id="T4"><label>Table 4</label><caption><p>Frequency of fracture types stratified by &#x003b2;3-Adrenergic Receptor genotype</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td align="center" colspan="2">Genotype</td><td align="center">P value<sup>a</sup></td></tr><tr><td></td><td colspan="2"><hr></hr></td><td></td></tr><tr><td></td><td align="center"><italic>Trp</italic>/<italic>Trp</italic></td><td align="center"><italic>Arg/Arg+</italic></td><td></td></tr><tr><td></td><td></td><td align="center"><italic>Trp/Arg</italic></td><td></td></tr></thead><tbody><tr><td align="left"><bold>Women (N)</bold></td><td align="center">385</td><td align="center">61</td><td></td></tr><tr><td align="left">Non-fracture</td><td align="center">232 (60.3)</td><td align="center">41 (67.2)</td><td></td></tr><tr><td align="left">Any fracture</td><td align="center">153 (39.7)</td><td align="center">20 (32.8)</td><td align="center">0.30</td></tr><tr><td align="left">Hip fracture</td><td align="center">37 (13.8)</td><td align="center">4 (8.9)</td><td align="center">0.66<sup>b</sup></td></tr><tr><td align="left">Vertebral fracture</td><td align="center">53 (18.6)</td><td align="center">5 (10.9)</td><td align="center">0.23</td></tr><tr><td align="left">Wrist/forearm</td><td align="center">54 (18.9)</td><td align="center">5 (10.9)</td><td align="center">0.21</td></tr><tr><td colspan="4"><hr></hr></td></tr><tr><td align="left"><bold>Men (N)</bold></td><td align="center">224</td><td align="center">41</td><td></td></tr><tr><td align="left">Non-fracture</td><td align="center">184 (82.1)</td><td align="center">32 (78.1)</td><td></td></tr><tr><td align="left">Any fracture</td><td align="center">40 (17.9)</td><td align="center">9 (22.0)</td><td align="center">0.53</td></tr><tr><td align="left">Hip fracture</td><td align="center">8 (4.2)</td><td align="center">2 (5.9)</td><td align="center">0.66<sup>b</sup></td></tr><tr><td align="left">Vertebral fracture</td><td align="center">17 (8.5)</td><td align="center">5 (13.5)</td><td align="center">0.33</td></tr><tr><td align="left">Wrist/forearm</td><td align="center">3 (1.6)</td><td align="center">1 (3.0)</td><td align="center">0.49<sup>b</sup></td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>Chi-square test, otherwise specified; <sup>b</sup>Fisher's exact test</p></table-wrap-foot></table-wrap><table-wrap position="float" id="T5"><label>Table 5</label><caption><p>Relationship between &#x003b2;3-Adrenergic Receptor genotypes and fracture risk</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td align="center">Any fracture</td><td align="center">Hip fracture</td><td align="center">Vertebral fracture</td><td align="center">Wrist/forearm<sup>b</sup></td></tr></thead><tbody><tr><td align="left"><bold>Women</bold></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">ADRB3 unadjusted<sup>a</sup></td><td align="center">0.74 (0.42, 1.31)</td><td align="center">0.66 (0.23,1.92)</td><td align="center">0.56 (0.21, 1.46)</td><td align="center">0.55 (0.21, 1.43)</td></tr><tr><td align="left">Adjusted for age (1)</td><td align="center">0.72 (0.40, 1.28)</td><td align="center">0.66 (0.22,1.96)</td><td align="center">0.55 (0.21, 1.43)</td><td align="center">0.54 (0.21, 1.42)</td></tr><tr><td align="left">Adjusted for FNBMD (2)</td><td align="center">0.84 (0.46, 1.55)</td><td align="center">0.83 (0.25, 2.77)</td><td align="center">0.62 (0.24, 1.64)</td><td align="center">0.61 (0.23, 1.61)</td></tr><tr><td align="left">Adjusted for BMI (3)</td><td align="center">0.76 (0.42, 1.37)</td><td align="center">0.82 (0.27, 2.44)</td><td align="center">0.60 (0.23, 1.56)</td><td align="center">0.57 (0.22, 1.50)</td></tr><tr><td align="left">Adjusted for (1) and (2)</td><td align="center">0.84 (0.45, 1.55)</td><td align="center">0.78 (0.23, 2.61)</td><td align="center">0.60 (0.23, 1.58)</td><td align="center">0.61 (0.23, 1.60)</td></tr><tr><td align="left">Adjusted for (1) and (3)</td><td align="center">0.74 (0.41, 1.33)</td><td align="center">0.70 (0.23, 2.16)</td><td align="center">0.57 (0.22, 1.51)</td><td align="center">0.56 (0.22, 1.48)</td></tr><tr><td align="left">Adjusted for (1) and (2) and (3)</td><td align="center">0.83 (0.45, 1.53)</td><td align="center">0.75 (0.22, 2.56)</td><td align="center">0.60 (0.23, 1.59)</td><td align="center">0.61 (0.23, 1.60)</td></tr><tr><td colspan="5"><hr></hr></td></tr><tr><td align="left"><bold>Men</bold></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">ADRB3 unadjusted<sup>a</sup></td><td align="center">1.29 (0.57, 2.92)</td><td align="center">1.39 (0.28, 6.76)</td><td align="center">1.69 (0.59, 4.88)</td><td align="center">1.84 0.19, 18.18)</td></tr><tr><td align="left">Adjusted for age (1)</td><td align="center">1.57 (0.68, 3.65)</td><td align="center">2.87 (0.50, 16.39)</td><td align="center">2.03 (0.69, 6.02)</td><td align="center">-</td></tr><tr><td align="left">Adjusted for FNBMD (2)</td><td align="center">1.25 (0.52, 3.04)</td><td align="center">1.47 (0.29, 7.46)</td><td align="center">1.88 (0.62, 5.71)</td><td align="center">-</td></tr><tr><td align="left">Adjusted for BMI (3)</td><td align="center">1.28 (0.56, 2.89)</td><td align="center">1.34 (0.27, 6.58)</td><td align="center">1.66 (0.57, 4.78)</td><td align="center">-</td></tr><tr><td align="left">Adjusted for (1) and (2)</td><td align="center">1.47 (0.60, 3.62)</td><td align="center">3.03 (0.52, 17.54)</td><td align="center">2.15 (0.69, 6.67)</td><td align="center">-</td></tr><tr><td align="left">Adjusted for (1) and (3)</td><td align="center">1.57 (0.67, 3.65)</td><td align="center">2.85 (0.50, 16.39)</td><td align="center">2.02 (0.68, 6.02)</td><td align="center">-</td></tr><tr><td align="left">Adjusted for (1) and (2) and (3)</td><td align="center">1.46 (0.59, 3.62)</td><td align="center">2.88 (0.48, 7.24)</td><td align="center">2.15 (0.69, 6.67)</td><td align="center">-</td></tr></tbody></table><table-wrap-foot><p>Values are Odds ratio and 95% CI;</p><p><sup>a</sup><italic>Arg</italic>-allele carriers were considered the risk factor in the model and <italic>Trp/Trp </italic>genotype was the reference group.</p><p><sup>b</sup>adjusted OR was not calculated for wrist/forearm fracture in men due to small number of fracture.</p></table-wrap-foot></table-wrap></sec></sec><sec><title>Discussion</title><p>Obesity is associated with increased BMD and reduced fracture risk [<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B37">37</xref>]. Studies on polymorphisms of the ADRB3 gene and their association with BMD have been reported in the Japanese population [<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B38">38</xref>], but not in Caucasians. The present data further suggested that there was no significant association between ADRB3 genotypes and fracture risk in a Caucasian population.</p><p>The ADRB3 genotypes have largely been investigated for association with BMI in the Japanese population, from whom a significant association has been reported. The association was characterised by individuals with the <italic>Arg </italic>allele having higher BMI than individuals without the <italic>Arg </italic>allele. In this study, individuals with the <italic>Arg </italic>allele also had higher BMI than individuals without the <italic>Arg </italic>allele, but the difference did not reach statistical significance. Nevertheless, by using the Bayesian approach (i.e., updating the current data with previous data) it was found that there was a 99% probability that BMI among those with the <italic>Arg </italic>allele was higher than those without the <italic>Arg </italic>allele.</p><p>The frequency of the <italic>Arg </italic>allele in the present study was similar to that reported for the Australian population [<xref ref-type="bibr" rid="B39">39</xref>] and other Caucasian populations [<xref ref-type="bibr" rid="B40">40</xref>,<xref ref-type="bibr" rid="B41">41</xref>], but lower than that of Asian populations [<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B42">42</xref>-<xref ref-type="bibr" rid="B44">44</xref>]. To our knowledge, the present study is the first to investigate the association between ADRB3 genotypes and BMD and fracture risk in Caucasian population.</p><p>The present results suggest there was no statistically significant association between ADRB3 genotypes and BMD. This is consistent with previous findings in Japanese women [<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B38">38</xref>] (Table <xref ref-type="table" rid="T6">6</xref>). It has been suggested that the association between ADRB3 and BMD are more likely to be found in obese individuals than in non-obese individuals. However, in the present study, the non-significant association between ADRB3 and BMD was observed in both obese and non-obese individuals (data not shown).</p><table-wrap position="float" id="T6"><label>Table 6</label><caption><p>&#x003b2;3AR genotypes and bone mineral density: summary of previous and present studies</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left">First Author and genotypes</td><td align="center">N (%)</td><td align="center">Femoral neck BMD (mean; SD)</td><td align="center">Lumbar spine BMD (mean; SD)</td><td align="center">Total body BMD (mean; SD)</td></tr></thead><tbody><tr><td align="left">Ogawa et al. [38]<sup>a</sup></td><td></td><td></td><td></td><td></td></tr><tr><td align="left"><italic>Trp</italic>/<italic>Trp </italic>and <italic>Trp</italic>/<italic>Arg</italic></td><td align="center">267 (95.4)</td><td align="center">NA</td><td align="center">0.145 (1.36)</td><td align="center">0.432 (0.93)</td></tr><tr><td align="left"><italic>Arg</italic>/<italic>Arg</italic></td><td align="center">13 (4.6)</td><td align="center">NA</td><td align="center">0.179 (2.11)</td><td align="center">-0.135 (0.93)</td></tr><tr><td align="left">P-value</td><td></td><td align="center">NA</td><td align="center">NS</td><td align="center">0.033</td></tr><tr><td align="left">Kasumata et al. [27]<sup>b</sup></td><td></td><td></td><td></td><td></td></tr><tr><td align="left"><italic>Trp</italic>/<italic>Trp </italic>and <italic>Trp</italic>/<italic>Arg</italic></td><td align="center">142 (97.6)</td><td align="center">NA</td><td align="center">NA</td><td align="center">NA</td></tr><tr><td align="left"><italic>Arg</italic>/<italic>Arg</italic></td><td align="center">3 (2.4)</td><td align="center">NA</td><td align="center">NA</td><td align="center">NA</td></tr><tr><td align="left">P-value</td><td></td><td align="center">NS</td><td align="center">NS</td><td align="center">NA</td></tr><tr><td align="left">The present study</td><td></td><td></td><td></td><td></td></tr><tr><td align="left"><italic>Trp</italic>/<italic>Trp</italic></td><td align="center">385 (86.3)</td><td align="center">0.76 (0.13)</td><td align="center">1.00 (0.18)</td><td align="center">NA</td></tr><tr><td align="left"><italic>Trp</italic>/<italic>Arg </italic>and <italic>Arg</italic>/<italic>Arg</italic></td><td align="center">61 (13.7)</td><td align="center">0.79 (0.13)</td><td align="center">1.04 (0.21)</td><td align="center">NA</td></tr><tr><td align="left">P-value</td><td></td><td align="center">0.238</td><td align="center">0.113</td><td align="center">NA</td></tr></tbody></table><table-wrap-foot><p>NA, not available; NS, non-significant. <sup>a</sup>Values were shown as Z-scores BMD. <sup>b </sup>Data were not shown; the authors only stated in text: "No association was demonstrated between the ER, CaSR or &#x003b2;3-AR genotypes and BMD, either alone or in relation to other polymorphisms".</p></table-wrap-foot></table-wrap><p>In this current study, no significant association was observed in either sex. However, while women with the <italic>Arg </italic>allele appeared to have lower risk of fracture, men with the <italic>Arg </italic>allele had increased risk of fracture. The reason for this opposite trend was not apparent; however, stochastic fluctuation can be a contributory factor.</p><p>BMD is largely determined by genetic factors [<xref ref-type="bibr" rid="B45">45</xref>], and as BMI is a strong predictor of BMD [<xref ref-type="bibr" rid="B14">14</xref>], we thus hypothesized that ADRB3, being a candidate gene for BMI, would have pleiotropic effect on both BMD and BMI. However, the present results did not support the hypothesis, and the effect of ADRB3 seemed to be BMI specific, and the effect of ADRB3 on BMI showed a 0.31 kg/m<sup>2 </sup>difference between genotypes.</p><p>The present study was based on a relatively large sample size which has been followed up for a reasonably long period of time (up to 15 years), which allows more precise delineation of effect than smaller studies. Moreover, subjects in this study are of Caucasian background, and the present results are likely to be valid in similar populations of elderly Caucasians. However, a potential limitation is that with the low prevalence of the <italic>Arg </italic>allele in the ADRB3 gene there are small numbers of subjects with the <italic>Arg</italic>/<italic>Arg </italic>genotype. Since fracture is a relatively rare event, the lack of fracture cases in individuals with <italic>Arg </italic>allele could limit the power of the study.</p><p>Furthermore, this study examined only one polymorphism which may not adequately capture the polymorphic variation within the gene, and hence limited the chance of finding an underlying association. There is also a lack of association studies investigating the relationship between ADRB3 genotypes and BMD, and no studies have investigated the association between ADRB3 genotypes and fracture risk, therefore no prior information could be drawn to reinforce our findings via the Bayesian approach.</p></sec><sec><title>Conclusion</title><p>In summary, the present data suggested that in elderly men and women, there is a weak positive association between <italic>Arg </italic>allele of the ADRB3 gene and BMI. However, no significant associations were observed between ADRB3 polymorphisms and BMD or fracture risk, and it seems unlikely that ADRB3 has a significant predictive value for osteoporotic fracture risk.</p></sec><sec><title>Abbreviations</title><p>All abbreviations are defined in the text.</p></sec><sec><title>Competing interests</title><p>Dr John Eisman who serves as a consultant and receives corporate appointment from Aventis, Eli Lilly and Company, Merck Sharp &#x00026; Dohme Ltd., Novartis, MPS Pharmaceuticals, Organon, Roche and Servier.</p><p>All other authors have neither financial nor non-financial competing interests that may be affected from the publication of the manuscript.</p></sec><sec><title>Authors' contributions</title><p>CYW and NDN obtained and analysed data, and drafted the manuscript. NM performed the genotyping and was initially involved in the conceptual discussion of the project. JRC had an active role in the conduct of the Dubbo Osteoporosis Epidemiology Study. JAE established the Dubbo Osteoporosis Epidemiology Study. TVN had an active role in the Dubbo Osteoporosis Epidemiology Study since its inception; he was involved in the study design, data analysis, and in the conceptual discussion of the project. All authors contributed to the last version of the manuscript.</p></sec><sec><title>Pre-publication history</title><p>The pre-publication history for this paper can be accessed here:</p><p><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2350/7/57/prepub"/></p></sec></body><back><ack><sec><title>Acknowledgements</title><p>We gratefully acknowledge the assistance of Sr Janet Watters and Donna Reeves for the interview, data collection and measurement bone mineral density. We also appreciate the invaluable help of the staff of Dubbo base hospital. This works has been partly supported by the National Health and Medical Research Council of Australia and untied educational grants from GE-Lunar, Merck Australia, Eli Lilly International and Aventis Australia.</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Flegal</surname><given-names>KM</given-names></name><name><surname>Graubard</surname><given-names>BI</given-names></name><name><surname>Williamson</surname><given-names>DF</given-names></name><name><surname>Gail</surname><given-names>MH</given-names></name></person-group><article-title>Excess deaths associated with underweight, overweight, and obesity</article-title><source>JAMA</source><year>2005</year><volume>293</volume><fpage>1861</fpage><lpage>1867</lpage><pub-id pub-id-type="pmid">15840860</pub-id><pub-id pub-id-type="doi">10.1001/jama.293.15.1861</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Andreyeva</surname><given-names>T</given-names></name><name><surname>Sturm</surname><given-names>R</given-names></name><name><surname>Ringel</surname><given-names>JS</given-names></name></person-group><article-title>Moderate and severe obesity have large differences in health care costs</article-title><source>Obes Res</source><year>2004</year><volume>12</volume><fpage>1936</fpage><lpage>1943</lpage><pub-id pub-id-type="pmid">15687394</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kumanyika</surname><given-names>S</given-names></name><name><surname>Jeffery</surname><given-names>RW</given-names></name><name><surname>Morabia</surname><given-names>A</given-names></name><name><surname>Ritenbaugh</surname><given-names>C</given-names></name><name><surname>Antipatis</surname><given-names>VJ</given-names></name></person-group><article-title>Obesity prevention: the case for action</article-title><source>Int J Obes Relat Metab Disord</source><year>2002</year><volume>26</volume><fpage>425</fpage><lpage>436</lpage><pub-id pub-id-type="pmid">11896500</pub-id><pub-id pub-id-type="doi">10.1038/sj.ijo.0801938</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kanis</surname><given-names>JA</given-names></name><name><surname>Melton</surname><given-names>LJ</given-names></name><name><surname>Christiansen</surname><given-names>C</given-names></name><name><surname>Johnston</surname><given-names>CC</given-names></name><name><surname>Khaltaev</surname><given-names>N</given-names></name></person-group><article-title>The diagnosis of osteoporosis</article-title><source>J Bone Miner Res</source><year>1994</year><volume>9</volume><fpage>1137</fpage><lpage>1141</lpage><pub-id pub-id-type="pmid">7976495</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hedley</surname><given-names>AA</given-names></name><name><surname>Ogden</surname><given-names>CL</given-names></name><name><surname>Johnson</surname><given-names>CL</given-names></name><name><surname>Carroll</surname><given-names>MD</given-names></name><name><surname>Curtin</surname><given-names>LR</given-names></name><name><surname>Flegal</surname><given-names>KM</given-names></name></person-group><article-title>Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002</article-title><source>JAMA</source><year>2004</year><volume>291</volume><fpage>2847</fpage><lpage>2850</lpage><pub-id pub-id-type="pmid">15199035</pub-id><pub-id pub-id-type="doi">10.1001/jama.291.23.2847</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pruzansky</surname><given-names>ME</given-names></name><name><surname>Turano</surname><given-names>M</given-names></name><name><surname>Luckey</surname><given-names>M</given-names></name><name><surname>Senie</surname><given-names>R</given-names></name></person-group><article-title>Low body weight as a risk factor for hip fracture in both black and white women</article-title><source>J Orthop Res</source><year>1989</year><volume>7</volume><fpage>192</fpage><lpage>197</lpage><pub-id pub-id-type="pmid">2918419</pub-id><pub-id pub-id-type="doi">10.1002/jor.1100070206</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>LW</given-names></name><name><surname>Wang</surname><given-names>MQ</given-names></name><name><surname>Fu</surname><given-names>Q</given-names></name></person-group><article-title>Risk factors for hip fracture among southern older women</article-title><source>South Med J</source><year>1998</year><volume>91</volume><fpage>533</fpage><lpage>540</lpage><pub-id pub-id-type="pmid">9634114</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>del Puente</surname><given-names>A</given-names></name><name><surname>Postiglione</surname><given-names>A</given-names></name><name><surname>Esposito-del Puente</surname><given-names>A</given-names></name><name><surname>Carpinelli</surname><given-names>A</given-names></name><name><surname>Romano</surname><given-names>M</given-names></name><name><surname>Oriente</surname><given-names>P</given-names></name></person-group><article-title>Peripheral body fat has a protective role on bone mineral density in elderly women</article-title><source>Eur J Clin Nutr</source><year>1998</year><volume>52</volume><fpage>690</fpage><lpage>693</lpage><pub-id pub-id-type="pmid">9756127</pub-id><pub-id pub-id-type="doi">10.1038/sj.ejcn.1600630</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Margolis</surname><given-names>KL</given-names></name><name><surname>Ensrud</surname><given-names>KE</given-names></name><name><surname>Schreiner</surname><given-names>PJ</given-names></name><name><surname>Tabor</surname><given-names>HK</given-names></name></person-group><article-title>Body size and risk for clinical fractures in older women. Study of Osteoporotic Fractures Research Group</article-title><source>Ann Intern Med</source><year>2000</year><volume>133</volume><fpage>123</fpage><lpage>127</lpage><pub-id pub-id-type="pmid">10896638</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shiraki</surname><given-names>M</given-names></name><name><surname>Ito</surname><given-names>H</given-names></name><name><surname>Fujimaki</surname><given-names>H</given-names></name><name><surname>Higuchi</surname><given-names>T</given-names></name></person-group><article-title>Relation between body size and bone mineral density with special reference to sex hormones and calcium regulating hormones in elderly females</article-title><source>Endocrinol Jpn</source><year>1991</year><volume>38</volume><fpage>343</fpage><lpage>349</lpage><pub-id pub-id-type="pmid">1802674</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>ND</given-names></name><name><surname>Pongchaiyakul</surname><given-names>C</given-names></name><name><surname>Center</surname><given-names>JR</given-names></name><name><surname>Eisman</surname><given-names>JA</given-names></name><name><surname>Nguyen</surname><given-names>TV</given-names></name></person-group><article-title>Abdominal fat and hip fracture risk in the elderly: The Dubbo Osteoporosis Epidemiology Study</article-title><source>BMC Musculoskelet Disord</source><year>2005</year><volume>6</volume><fpage>11</fpage><pub-id pub-id-type="pmid">15727686</pub-id><pub-id pub-id-type="doi">10.1186/1471-2474-6-11</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Orozco</surname><given-names>P</given-names></name><name><surname>Nolla</surname><given-names>JM</given-names></name></person-group><article-title>Associations between body morphology and bone mineral density in premenopausal women</article-title><source>Eur J Epidemiol</source><year>1997</year><volume>13</volume><fpage>919</fpage><lpage>924</lpage><pub-id pub-id-type="pmid">9476822</pub-id><pub-id pub-id-type="doi">10.1023/A:1007309722100</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martinez Diaz-Guerra</surname><given-names>G</given-names></name><name><surname>Hawkins</surname><given-names>F</given-names></name><name><surname>Rapado</surname><given-names>A</given-names></name><name><surname>Ruiz Diaz</surname><given-names>MA</given-names></name><name><surname>Diaz-Curiel</surname><given-names>M</given-names></name></person-group><article-title>Hormonal and anthropometric predictors of bone mass in healthy elderly men: major effect of sex hormone binding globulin, parathyroid hormone and body weight</article-title><source>Osteoporos Int</source><year>2001</year><volume>12</volume><fpage>178</fpage><lpage>184</lpage><pub-id pub-id-type="pmid">11315235</pub-id><pub-id pub-id-type="doi">10.1007/s001980170127</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Blum</surname><given-names>M</given-names></name><name><surname>Harris</surname><given-names>SS</given-names></name><name><surname>Must</surname><given-names>A</given-names></name><name><surname>Phillips</surname><given-names>SM</given-names></name><name><surname>Rand</surname><given-names>WM</given-names></name><name><surname>Dawson-Hughes</surname><given-names>B</given-names></name></person-group><article-title>Weight and body mass index at menarche are associated with premenopausal bone mass</article-title><source>Osteoporos Int</source><year>2001</year><volume>12</volume><fpage>588</fpage><lpage>594</lpage><pub-id pub-id-type="pmid">11527058</pub-id><pub-id pub-id-type="doi">10.1007/s001980170082</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Christian</surname><given-names>JC</given-names></name><name><surname>Yu</surname><given-names>PL</given-names></name><name><surname>Slemenda</surname><given-names>CW</given-names></name><name><surname>Johnston</surname><given-names>CCJ</given-names></name></person-group><article-title>Heritability of bone mass: a longitudinal study in aging male twins</article-title><source>Am J Hum Genet</source><year>1989</year><volume>44</volume><fpage>429</fpage><lpage>433</lpage><pub-id pub-id-type="pmid">2916585</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pocock</surname><given-names>NA</given-names></name><name><surname>Eisman</surname><given-names>JA</given-names></name><name><surname>Hopper</surname><given-names>JL</given-names></name><name><surname>Yeates</surname><given-names>MG</given-names></name><name><surname>Sambrook</surname><given-names>PN</given-names></name><name><surname>Eberl</surname><given-names>S</given-names></name></person-group><article-title>Genetic determinants of bone mass in adults. A twin study</article-title><source>J Clin Invest</source><year>1987</year><volume>80</volume><fpage>706</fpage><lpage>710</lpage><pub-id pub-id-type="pmid">3624485</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>TV</given-names></name><name><surname>Howard</surname><given-names>GM</given-names></name><name><surname>Kelly</surname><given-names>PJ</given-names></name><name><surname>Eisman</surname><given-names>JA</given-names></name></person-group><article-title>Bone mass, lean mass, and fat mass: same genes or same environments?</article-title><source>Am J Epidemiol</source><year>1998</year><volume>147</volume><fpage>3</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">9440393</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nath</surname><given-names>SK</given-names></name><name><surname>Chakravarti</surname><given-names>A</given-names></name><name><surname>Chen</surname><given-names>CH</given-names></name><name><surname>Cooper</surname><given-names>R</given-names></name><name><surname>Weder</surname><given-names>A</given-names></name><name><surname>Schork</surname><given-names>NJ</given-names></name></person-group><article-title>Segregation analysis of blood pressure and body mass index in a rural US community</article-title><source>Hum Biol</source><year>2002</year><volume>74</volume><fpage>11</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">11931572</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Allison</surname><given-names>DB</given-names></name><name><surname>Kaprio</surname><given-names>J</given-names></name><name><surname>Korkeila</surname><given-names>M</given-names></name><name><surname>Koskenvuo</surname><given-names>M</given-names></name><name><surname>Neale</surname><given-names>MC</given-names></name><name><surname>Hayakawa</surname><given-names>K</given-names></name></person-group><article-title>The heritability of body mass index among an international sample of monozygotic twins reared apart</article-title><source>Int J Obes Relat Metab Disord</source><year>1996</year><volume>20</volume><fpage>501</fpage><lpage>506</lpage><pub-id pub-id-type="pmid">8782724</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Flicker</surname><given-names>L</given-names></name><name><surname>Hopper</surname><given-names>JL</given-names></name><name><surname>Rodgers</surname><given-names>L</given-names></name><name><surname>Kaymakci</surname><given-names>B</given-names></name><name><surname>Green</surname><given-names>RM</given-names></name><name><surname>Wark</surname><given-names>JD</given-names></name></person-group><article-title>Bone density determinants in elderly women: a twin study</article-title><source>J Bone Miner Res</source><year>1995</year><volume>10</volume><fpage>1607</fpage><lpage>1613</lpage><pub-id pub-id-type="pmid">8592936</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kannus</surname><given-names>P</given-names></name><name><surname>Palvanen</surname><given-names>M</given-names></name><name><surname>Kaprio</surname><given-names>J</given-names></name><name><surname>Parkkari</surname><given-names>J</given-names></name><name><surname>Koskenvuo</surname><given-names>M</given-names></name></person-group><article-title>Genetic factors and osteoporotic fractures in elderly people: prospective 25 year follow up of a nationwide cohort of elderly Finnish twins</article-title><source>Bmj</source><year>1999</year><volume>319</volume><fpage>1334</fpage><lpage>1337</lpage><pub-id pub-id-type="pmid">10567136</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>TV</given-names></name><name><surname>Esteban</surname><given-names>LM</given-names></name><name><surname>White</surname><given-names>CP</given-names></name><name><surname>Grant</surname><given-names>SF</given-names></name><name><surname>Center</surname><given-names>JR</given-names></name><name><surname>Gardiner</surname><given-names>EM</given-names></name><name><surname>Eisman</surname><given-names>JA</given-names></name></person-group><article-title>Contribution of the collagen I alpha1 and vitamin D receptor genes to the risk of hip fracture in elderly women</article-title><source>J Clin Endocrinol Metab</source><year>2005</year><volume>90</volume><fpage>6575</fpage><lpage>6579</lpage><pub-id pub-id-type="pmid">16159929</pub-id><pub-id pub-id-type="doi">10.1210/jc.2005-1153</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mann</surname><given-names>V</given-names></name><name><surname>Ralston</surname><given-names>SH</given-names></name></person-group><article-title>Meta-analysis of COL1A1 Sp1 polymorphism in relation to bone mineral density and osteoporotic fracture</article-title><source>Bone</source><year>2003</year><volume>32</volume><fpage>711</fpage><lpage>717</lpage><pub-id pub-id-type="pmid">12810179</pub-id><pub-id pub-id-type="doi">10.1016/S8756-3282(03)00087-5</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Takeuchi</surname><given-names>T</given-names></name><name><surname>Tsuboi</surname><given-names>T</given-names></name><name><surname>Arai</surname><given-names>M</given-names></name><name><surname>Togari</surname><given-names>A</given-names></name></person-group><article-title>Adrenergic stimulation of osteoclastogenesis mediated by expression of osteoclast differentiation factor in MC3T3-E1 osteoblast-like cells</article-title><source>Biochem Pharmacol</source><year>2001</year><volume>61</volume><fpage>579</fpage><lpage>586</lpage><pub-id pub-id-type="pmid">11239501</pub-id><pub-id pub-id-type="doi">10.1016/S0006-2952(00)00591-8</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname><given-names>RE</given-names></name><name><surname>Smith</surname><given-names>CK</given-names></name><name><surname>Bailey</surname><given-names>CS</given-names></name><name><surname>Voelkel</surname><given-names>EF</given-names></name><name><surname>Tashjian</surname><given-names>AHJ</given-names></name></person-group><article-title>Characterization of beta-adrenergic receptors on rat and human osteoblast-like cells and demonstration that beta-receptor agonists can stimulate bone resorption in organ culture</article-title><source>Bone Miner</source><year>1993</year><volume>23</volume><fpage>301</fpage><lpage>315</lpage><pub-id pub-id-type="pmid">7908582</pub-id></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fujisawa</surname><given-names>T</given-names></name><name><surname>Ikegami</surname><given-names>H</given-names></name><name><surname>Kawaguchi</surname><given-names>Y</given-names></name><name><surname>Ogihara</surname><given-names>T</given-names></name></person-group><article-title>Meta-analysis of the association of Trp64Arg polymorphism of beta 3-adrenergic receptor gene with body mass index</article-title><source>J Clin Endocrinol Metab</source><year>1998</year><volume>83</volume><fpage>2441</fpage><lpage>2444</lpage><pub-id pub-id-type="pmid">9661625</pub-id><pub-id pub-id-type="doi">10.1210/jc.83.7.2441</pub-id></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Katsumata</surname><given-names>K</given-names></name><name><surname>Nishizawa</surname><given-names>K</given-names></name><name><surname>Unno</surname><given-names>A</given-names></name><name><surname>Fujita</surname><given-names>Y</given-names></name><name><surname>Tokita</surname><given-names>A</given-names></name></person-group><article-title>Association of gene polymorphisms and bone density in Japanese girls</article-title><source>J Bone Miner Metab</source><year>2002</year><volume>20</volume><fpage>164</fpage><lpage>169</lpage><pub-id pub-id-type="pmid">11984699</pub-id><pub-id pub-id-type="doi">10.1007/s007740200023</pub-id></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Center</surname><given-names>JR</given-names></name><name><surname>Nguyen</surname><given-names>TV</given-names></name><name><surname>Schneider</surname><given-names>D</given-names></name><name><surname>Sambrook</surname><given-names>PN</given-names></name><name><surname>Eisman</surname><given-names>JA</given-names></name></person-group><article-title>Mortality after all major types of osteoporotic fracture in men and women: an observational study</article-title><source>Lancet</source><year>1999</year><volume>353</volume><fpage>878</fpage><lpage>882</lpage><pub-id pub-id-type="pmid">10093980</pub-id><pub-id pub-id-type="doi">10.1016/S0140-6736(98)09075-8</pub-id></citation></ref><ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>G</given-names></name><name><surname>Nguyen</surname><given-names>T</given-names></name><name><surname>Sambrook</surname><given-names>PN</given-names></name><name><surname>Kelly</surname><given-names>PJ</given-names></name><name><surname>Gilbert</surname><given-names>C</given-names></name><name><surname>Eisman</surname><given-names>JA</given-names></name></person-group><article-title>Symptomatic fracture incidence in elderly men and women: the Dubbo Osteoporosis Epidemiology Study (DOES)</article-title><source>Osteoporos Int</source><year>1994</year><volume>4</volume><fpage>277</fpage><lpage>282</lpage><pub-id pub-id-type="pmid">7812076</pub-id><pub-id pub-id-type="doi">10.1007/BF01623352</pub-id></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>TV</given-names></name><name><surname>Eisman</surname><given-names>JA</given-names></name><name><surname>Kelly</surname><given-names>PJ</given-names></name><name><surname>Sambrook</surname><given-names>PN</given-names></name></person-group><article-title>Risk factors for osteoporotic fractures in elderly men</article-title><source>Am J Epidemiol</source><year>1996</year><volume>144</volume><fpage>255</fpage><lpage>263</lpage><pub-id pub-id-type="pmid">8686694</pub-id></citation></ref><ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>TV</given-names></name><name><surname>Center</surname><given-names>JR</given-names></name><name><surname>Eisman</surname><given-names>JA</given-names></name></person-group><article-title>Osteoporosis in elderly men and women: effects of dietary calcium, physical activity, and body mass index</article-title><source>J Bone Miner Res</source><year>2000</year><volume>15</volume><fpage>322</fpage><lpage>331</lpage><pub-id pub-id-type="pmid">10703935</pub-id><pub-id pub-id-type="doi">10.1359/jbmr.2000.15.2.322</pub-id></citation></ref><ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Clement</surname><given-names>K</given-names></name><name><surname>Vaisse</surname><given-names>C</given-names></name><name><surname>Manning</surname><given-names>BS</given-names></name><name><surname>Basdevant</surname><given-names>A</given-names></name><name><surname>Guy-Grand</surname><given-names>B</given-names></name><name><surname>Ruiz</surname><given-names>J</given-names></name><name><surname>Silver</surname><given-names>KD</given-names></name><name><surname>Shuldiner</surname><given-names>AR</given-names></name><name><surname>Froguel</surname><given-names>P</given-names></name><name><surname>Strosberg</surname><given-names>AD</given-names></name></person-group><article-title>Genetic variation in the beta 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity</article-title><source>N Engl J Med</source><year>1995</year><volume>333</volume><fpage>352</fpage><lpage>354</lpage><pub-id pub-id-type="pmid">7609752</pub-id><pub-id pub-id-type="doi">10.1056/NEJM199508103330605</pub-id></citation></ref><ref id="B33"><citation citation-type="book"><person-group person-group-type="author"><collab>SPSS Inc.</collab></person-group><source>SPSS 13.0 Base User's Guide</source><year>2004</year><publisher-name>Chicago, IL , SPSS Inc.</publisher-name></citation></ref><ref id="B34"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Matthews</surname><given-names>RAJ</given-names></name></person-group><source>Facts versus factions: The use and abuse of subjectivity in scientific research: Barton, Cambridge, UK. </source><year>1998</year></citation></ref><ref id="B35"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Spiegelhalter</surname><given-names>DJ</given-names></name><name><surname>Abrams</surname><given-names>KR</given-names></name><name><surname>Myles</surname><given-names>JP</given-names></name></person-group><source>Bayesian Approaches to Clinical Trials and Health-Care Evaluation</source><year>2004</year><publisher-name>West Sussex, England , John Wiley &#x00026; Sons Ltd.</publisher-name></citation></ref><ref id="B36"><citation citation-type="book"><person-group person-group-type="author"><collab>SAS Institute Inc.</collab></person-group><article-title> Base SAS 9.1.3 Procedures Guide, Volumes 1-4.</article-title><source>Base SAS</source><year>2004</year><edition>9.1.3 (TS1M3)</edition><publisher-name>Cary, NC, USA , SAS Publishing</publisher-name></citation></ref><ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Leonard</surname><given-names>MB</given-names></name><name><surname>Shults</surname><given-names>J</given-names></name><name><surname>Wilson</surname><given-names>BA</given-names></name><name><surname>Tershakovec</surname><given-names>AM</given-names></name><name><surname>Zemel</surname><given-names>BS</given-names></name></person-group><article-title>Obesity during childhood and adolescence augments bone mass and bone dimensions</article-title><source>Am J Clin Nutr</source><year>2004</year><volume>80</volume><fpage>514</fpage><lpage>523</lpage><pub-id pub-id-type="pmid">15277178</pub-id></citation></ref><ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ogawa</surname><given-names>S</given-names></name><name><surname>Emi</surname><given-names>M</given-names></name><name><surname>Shiraki</surname><given-names>M</given-names></name><name><surname>Hosoi</surname><given-names>T</given-names></name><name><surname>Orimo</surname><given-names>H</given-names></name><name><surname>Ouchi</surname><given-names>Y</given-names></name><name><surname>Inoue</surname><given-names>S</given-names></name></person-group><article-title>Association of amino acid variation (Trp64Arg) in the beta3-adrenergic receptor gene with bone mineral density</article-title><source>Geriatrics and Gerontology International</source><year>2002</year><volume>2</volume><fpage>138</fpage><lpage>142</lpage><pub-id pub-id-type="doi">10.1046/j.1444-1586.2002.00037.x</pub-id></citation></ref><ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kurabayashi</surname><given-names>T</given-names></name><name><surname>Carey</surname><given-names>DG</given-names></name><name><surname>Morrison</surname><given-names>NA</given-names></name></person-group><article-title>The beta 3-adrenergic receptor gene Trp64Arg mutation is overrepresented in obese women. Effects on weight, BMI, abdominal fat, blood pressure, and reproductive history in an elderly Australian population</article-title><source>Diabetes</source><year>1996</year><volume>45</volume><fpage>1358</fpage><lpage>1363</lpage><pub-id pub-id-type="pmid">8826971</pub-id></citation></ref><ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>LS</given-names></name><name><surname>Lonnqvist</surname><given-names>F</given-names></name><name><surname>Luthman</surname><given-names>H</given-names></name><name><surname>Arner</surname><given-names>P</given-names></name></person-group><article-title>Phenotypic characterization of the Trp64Arg polymorphism in the beta 3-adrenergic receptor gene in normal weight and obese subjects</article-title><source>Diabetologia</source><year>1996</year><volume>39</volume><fpage>857</fpage><lpage>860</lpage><pub-id pub-id-type="pmid">8817112</pub-id><pub-id pub-id-type="doi">10.1007/s001250050521</pub-id></citation></ref><ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oksanen</surname><given-names>L</given-names></name><name><surname>Mustajoki</surname><given-names>P</given-names></name><name><surname>Kaprio</surname><given-names>J</given-names></name><name><surname>Kainulainen</surname><given-names>K</given-names></name><name><surname>Janne</surname><given-names>O</given-names></name><name><surname>Peltonen</surname><given-names>L</given-names></name><name><surname>Kontula</surname><given-names>K</given-names></name></person-group><article-title>Polymorphism of the beta 3-adrenergic receptor gene in morbid obesity</article-title><source>Int J Obes Relat Metab Disord</source><year>1996</year><volume>20</volume><fpage>1055</fpage><lpage>1061</lpage><pub-id pub-id-type="pmid">8968849</pub-id></citation></ref><ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hao</surname><given-names>K</given-names></name><name><surname>Peng</surname><given-names>S</given-names></name><name><surname>Xing</surname><given-names>H</given-names></name><name><surname>Yu</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>A</given-names></name><name><surname>Hong</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Zhu</surname><given-names>G</given-names></name><name><surname>Huo</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>D</given-names></name><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>Ronnenberg</surname><given-names>A</given-names></name><name><surname>Wu</surname><given-names>D</given-names></name><name><surname>Niu</surname><given-names>T</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name></person-group><article-title>beta(3) Adrenergic receptor polymorphism and obesity-related phenotypes in hypertensive patients</article-title><source>Obes Res</source><year>2004</year><volume>12</volume><fpage>125</fpage><lpage>130</lpage><pub-id pub-id-type="pmid">14742851</pub-id></citation></ref><ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Matsushita</surname><given-names>H</given-names></name><name><surname>Kurabayashi</surname><given-names>T</given-names></name><name><surname>Tomita</surname><given-names>M</given-names></name><name><surname>Kato</surname><given-names>N</given-names></name><name><surname>Tanaka</surname><given-names>K</given-names></name></person-group><article-title>Effects of uncoupling protein 1 and beta3-adrenergic receptor gene polymorphisms on body size and serum lipid concentrations in Japanese women</article-title><source>Maturitas</source><year>2003</year><volume>45</volume><fpage>39</fpage><lpage>45</lpage><pub-id pub-id-type="pmid">12753942</pub-id><pub-id pub-id-type="doi">10.1016/S0378-5122(03)00088-4</pub-id></citation></ref><ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kadowaki</surname><given-names>H</given-names></name><name><surname>Yasuda</surname><given-names>K</given-names></name><name><surname>Iwamoto</surname><given-names>K</given-names></name><name><surname>Otabe</surname><given-names>S</given-names></name><name><surname>Shimokawa</surname><given-names>K</given-names></name><name><surname>Silver</surname><given-names>K</given-names></name><name><surname>Walston</surname><given-names>J</given-names></name><name><surname>Yoshinaga</surname><given-names>H</given-names></name><name><surname>Kosaka</surname><given-names>K</given-names></name><name><surname>Yamada</surname><given-names>N</given-names></name><etal></etal></person-group><article-title>A mutation in the beta 3-adrenergic receptor gene is associated with obesity and hyperinsulinemia in Japanese subjects</article-title><source>Biochem Biophys Res Commun</source><year>1995</year><volume>215</volume><fpage>555</fpage><lpage>560</lpage><pub-id pub-id-type="pmid">7487991</pub-id><pub-id pub-id-type="doi">10.1006/bbrc.1995.2500</pub-id></citation></ref><ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Livshits</surname><given-names>G</given-names></name><name><surname>Deng</surname><given-names>HW</given-names></name><name><surname>Nguyen</surname><given-names>TV</given-names></name><name><surname>Yakovenko</surname><given-names>K</given-names></name><name><surname>Recker</surname><given-names>RR</given-names></name><name><surname>Eisman</surname><given-names>JA</given-names></name></person-group><article-title>Genetics of bone mineral density: evidence for a major pleiotropic effect from an intercontinental study</article-title><source>J Bone Miner Res</source><year>2004</year><volume>19</volume><fpage>914</fpage><lpage>923</lpage><pub-id pub-id-type="pmid">15125790</pub-id><pub-id pub-id-type="doi">10.1359/JBMR.040132</pub-id></citation></ref></ref-list></back></article> 